May 13, 2019
Lilly's CYRAMZA® (ramucirumab) Becomes First FDA-Approved Biomarker-Driven Therapy in Patients with Hepatocellular Carcinoma
Apr 08, 2019
ABK Biomedical Raises $30M in Series B Financing
Apr 08, 2019
Blue Faery Grants Liver Cancer Research Award
Feb 18, 2019
Global Cholangiocarcinoma (CCA) Market Insights 2017-2019 & 2028 - Disease Understanding, Epidemiology, Segmentation, Management, Outlook, & Drugs Uptake
Feb 18, 2019
The global liver cancer diagnostics market size is expected to reach USD 15.4 billion by 2025
Jan 21, 2019
Australian Patient Treated With DC Bead LUMI(TM), the First Commercially Available Radiopaque Drug-Eluting Bead
Nov 27, 2018
Antios Therapeutics Raises $25 Million in Oversubscribed Series A Financing to Pursue Hepatitis B Cure
Oct 21, 2018
LSK BioPharma and Jiangsu Hengrui Medicine Announce Global Clinical Collaboration to Evaluate the Combination of Anti-Angiogenesis and Immuno-Oncology Therapy for Patients with Advanced Hepatocellular Carcinoma (HCC)
Oct 09, 2018
Global Cancer Center Offers Patients Chance to Reduce Metastatic Liver Tumor with Simple Ablation
Oct 08, 2018
Hepatocellular Carcinoma- Rich Clinical Pipeline can Lead to an Increasing Market Size of USD 3.8 Billion by 2027 for G8 Countries
Oct 01, 2018
Liver Cancer is on the Rise Despite Increasing Number of Treatments
Sep 19, 2018
Renowned Philadelphia Surgeon Named New Medical Director for Capital Health Cancer Center
Sep 04, 2018
SillaJen and Lee's Pharmaceutical Announce First Patient Enrolled in the PHOCUS Trial in China Phase 3 Clinical Trial for Oncolytic Immunotherapy, Pexa-Vec, in Liver Cancer
Aug 19, 2018
Singapore's first clinical trial approval for T cell engineered (TCR) immunotherapy for treatment of Liver cancer
Aug 16, 2018
Eisai And Merck Announce FDA Approval Of LENVIMA® (lenvatinib) Capsules For First-line Treatment Of Unresectable Hepatocellular Carcinoma (HCC)
Aug 16, 2018
Sirnaomics Oncology IND Receives Green Light from US FDA to Initiate Study for Treatment of Cholangiocarcinoma
Jun 11, 2018
Merck KGaA, Darmstadt, Germany Provides Update on Tepotinib Phase II Results in Advanced Hepatocellular Carcinoma
Jun 05, 2018
Exact Sciences, Mayo Clinic Researchers Identify Blood-Based DNA Biomarker Panel to Accurately Diagnose Hepatocellular Carcinoma
Jun 04, 2018
Eiger Announces HDV Phase 2 Program Oral Presentation and Investigator / Key Opinion Leader Reception for Planned HDV Phase 3 D-LIVR Study at Global Hepatitis Summit 2018(TM)
May 27, 2018
Lion TCR receives US$ 20 million to fund its personalized T cell therapy clinical trials against Liver cancer